Brief: ViroGates Announces Distribution Agreement In US, Directed Share Issue

ViroGates A/S

15/10/2024 07:49

Oct 15 (Reuters) - ViroGates A/S  VIROG.CO :
    * SAID ON MONDAY CO ANNOUNCES AN AGREEMENT WITH US-BASED
SUPAR
HEALTH TO DISTRIBUTE ITS BLOOD TEST FOR CHRONIC INFLAMMATION
WITHIN THE UNITED STATES
    * SUPAR HEALTH HAS PLACED AN INITIAL BINDING ORDER, SIZE
UNDISCLOSED, WITH VIROGATES, WHICH WILL BE DELIVERED OVER
APPROXIMATELY 18 MONTHS
    * VIROGATES WILL RELEASE A DIRECTED ISSUE OF NOM. 1,289,510
SHARES
TO SUPAR REMEDY LLC AT A TOTAL SUBSCRIPTION PRICE OF
APPROXIMATELY 8.2 MILLION DKK
    * AGREEMENT WILL NOT HAVE IMPLICATIONS FOR VIROGATES’
FINANCIAL
EXPECTATIONS FOR 2024, CO MAINTAINS GUIDANCE

        
 Source text for Workspace:  urn:newsml:reuters.com:*:nMFN9KWdTt
 Further company coverage:  VIROG.CO  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))